1. Home
  2. LSTA vs XBP Comparison

LSTA vs XBP Comparison

Compare LSTA & XBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSTA
  • XBP
  • Stock Information
  • Founded
  • LSTA 1980
  • XBP N/A
  • Country
  • LSTA United States
  • XBP United Kingdom
  • Employees
  • LSTA N/A
  • XBP N/A
  • Industry
  • LSTA Misc Health and Biotechnology Services
  • XBP Business Services
  • Sector
  • LSTA Health Care
  • XBP Consumer Discretionary
  • Exchange
  • LSTA Nasdaq
  • XBP Nasdaq
  • Market Cap
  • LSTA 31.2M
  • XBP 31.2M
  • IPO Year
  • LSTA N/A
  • XBP N/A
  • Fundamental
  • Price
  • LSTA $2.61
  • XBP $1.06
  • Analyst Decision
  • LSTA Strong Buy
  • XBP
  • Analyst Count
  • LSTA 1
  • XBP 0
  • Target Price
  • LSTA $15.00
  • XBP N/A
  • AVG Volume (30 Days)
  • LSTA 66.3K
  • XBP 29.9K
  • Earning Date
  • LSTA 02-27-2025
  • XBP 11-12-2024
  • Dividend Yield
  • LSTA N/A
  • XBP N/A
  • EPS Growth
  • LSTA N/A
  • XBP N/A
  • EPS
  • LSTA N/A
  • XBP N/A
  • Revenue
  • LSTA N/A
  • XBP $157,146,000.00
  • Revenue This Year
  • LSTA N/A
  • XBP N/A
  • Revenue Next Year
  • LSTA N/A
  • XBP N/A
  • P/E Ratio
  • LSTA N/A
  • XBP N/A
  • Revenue Growth
  • LSTA N/A
  • XBP N/A
  • 52 Week Low
  • LSTA $2.19
  • XBP $0.79
  • 52 Week High
  • LSTA $4.20
  • XBP $4.33
  • Technical
  • Relative Strength Index (RSI)
  • LSTA 42.17
  • XBP 50.51
  • Support Level
  • LSTA $2.45
  • XBP $0.97
  • Resistance Level
  • LSTA $2.74
  • XBP $1.10
  • Average True Range (ATR)
  • LSTA 0.32
  • XBP 0.06
  • MACD
  • LSTA -0.05
  • XBP -0.00
  • Stochastic Oscillator
  • LSTA 16.48
  • XBP 64.29

About LSTA Lisata Therapeutics Inc.

Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.

About XBP XBP Europe Holdings Inc.

XBP Europe Holdings Inc is a pan-European integrator of bills, payments, and related solutions and services seeking to enable digital transformation. It provides business process management solutions with proprietary software suites and deep domain expertise, serving as a technology and operations partner for its clients' strategic journeys and streamlining their complex, disconnected payment processes. It has two segments Bills and Payments focusing on optimizing how bills and payments are processed by businesses of all sizes and industries and Technology focuses on sales of recurring and perpetual software licenses and related maintenance, hardware solutions, and related maintenance and professional services. It generates the majority of its revenue from the Bills and Payments segment.

Share on Social Networks: